Group items tagged

Encouraging news about higher U.S. consumer spending and a Greek bank merger pushed Hong Kong higher in heavier trading. In addition, completion of Bank of America's sale of China Construction Bank removed uncertainty from the market.

Here is a list of top fifteen stocks that are likely to be in focus today: Tata Motors Ltd: India's largest automobile company, posted its first loss in 25 quarters after a one-time charge of Rs 2,493 crore on account of Jaguar Land Rover vehicles damaged in the Tianjin Port explosion in August, foreign exchange revaluation and higher depreciation and amortisation expenses in the JLR business. Grasim Industries Ltd: The company which decided to merge with group company Aditya Birla Chemicals India LtdBSE -1.38 % earlier this year, plans to refinance the latter's Rs.1,200 crore loans and transfer them to its books once the merger is complete in the December quarter, said a media report. Coal India Ltd: State-run Coal IndiaBSE -1.58 % ( CILBSE -1.58 %) will invest Rs 6,000 crore to set up 1,000 MW of solar power generation capacity over the next five to six years, according to a senior company executive. Tata Steel Ltd: Forced to go for more restructuring of its UK business due to a "challenging marketplace", Tata SteelBSE -0.55 % will sell its Long Products Europe business by the end of the current financial year.

RCom - "Reliance Communications" is going to talk with shareholders of telecom operator Aircel for a potential merger of the wireless or mobile businesses for both of the companies. The idea is to mutually derive estimated substantial benefits of in-country consolidation, including operating expenditure (opex) & capital expenditure synergies & revenue enhancement, RCom told in a statement.

Not only do companies have the potential to achieve what Novavax was able to under the right circumstances, but the industry is also full of big mergers and acquisitions. Early-stage companies develop clinical trial pipelines. Larger companies may then target these smaller firms as buyout candidates. For instance, Merck (NYSE: MRK) bought cancer drug research company VelosBio Inc. from Pappas Capital and other investors for $2.75 billion. Gilead Sciences (NASDAQ: GILD) picked up Immunomedics for $21 billion to gain access to a breast cancer treatment, Trodelvy. The list goes on. In this article, we'll look at a few current and former biotech penny stocks that have continued demonstrating strength in the stock market in 2021.

Wall Street is adding momentum for bullish investors with the help of Google's $12.5 billion acquisition of Motorola Mobility. Investors are moving back to stocks cautiously.

Airlines have had a tough year and have been the victim of analyst flip flopping on their future. Their close ties with the state of the economy have discouraged buying but some of these look ripe for a contrarian buy.